TRICHOPOULOU A. Eating out of home and its correlates in 10 European countries. The European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2007; 10: 1515-25. 756. ORLOW I, BEGG CB, COTIGNOLA J, ROY P, HUMMER AJ, CLAS BA, MUJUMDAR U, CANCHOLA R, ARMSTRONG BK, KRICKER A, MARRETT LD, MILLIKAN RC, GRUBER SB, ANTON-CULVER H, ZANETTI R, GALLAGHER RP, DWYER T, REBBECK TR, KANETSKY PA, WILCOX H, BUSAM K, FROM L, BERWICK M; GEM STUDY GROUP. CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 2007; 127: 1234-43. 757. PACCHIONI D, MARTONE T, GHISOLFI G, BUSSOLATI G, TIZZANI A, CASETTA G, VINEIS P. Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer. Carcinogenesis 1997; 18: 1659-61. 758. PACI E, COVIELLO E, MICCINESI G, PULITI D, CORTESI L, DE LISI V, FERRETTI S, MANGONE L, PERLANGELI V, PONTI A, RAVAIOLI A, DE' BIANCHI PS, SEGNAN N, STRACCI F, TUMINO R, ZARCONE M, ZORZI M, ZAPPA M; IMPACT WORKING GROUP. Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis. Eur J Cancer 2008; 44: 858-65. (IF 4.454) 759. PACI E, GIORGI D, GIORDANO L, KROGH V, SASSOLI P. Programmi di screening mammografico in Emilia Romagna, Piemonte e Toscana. Attualità in Senologia 1999; 24: 51-52. 760. PACI E, PONTI A, CROCETTI E, ZAPPA M, SEGNAN N. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005; 97: 1853-4. 761. PACI E, PONTI A, ZAPPA M, PATRIARCA S, FALINI P, DELMASTRO G, BIANCHI S, SAPINO A, VEZZOSI V, SENORE C, CROCETTI E, FRIGERIO A, ZANETTI R, DEL TURCO MR, SEGNAN N. Early diagnosis, not differential treatment, explains better survival in service screening. Eur J Cancer 2005; 41: 2728-34. 762. PACI E, SEGNAN N. Salute della donna e Screening in Oncologia. Epidemiol Prev 1996; 20: 143-5. 763. PAGANI L, GUALA A, CAMPRA D, PAOLETTI R, LEONARDI G, PASTORE G. Efforts toward Rubella elimination and improved quality of health care services. Clin Infect Dis 2005; 40: 1208-9. 764. PAGANO E, BO S, PETRINCO M, ROSATO R, MERLETTI F, GREGORI D. Factors affecting hospitalization costs in Type 2 diabetic patients. J Diabetes Complications <strong>2009</strong>; 23: 1-6. (IF 2.017) 765. PAGANO E, CICCONE G, GALASSI C, SEGNAN N, MERLETTI F, E GRUPPO DI LAVORO RELAZIONE EPIDEMIOLOGICA. Relazione sanitaria sull’oncologia in Piemonte: aspetti epidemiologici. Torino, <strong>CPO</strong>-Piemonte, Regione Piemonte, Rete Oncologica, marzo 2005. 766. PAGANO E, CICCONE G, IACOMUSSI S, DIRINDIN N. La mobilità per motivi sanitari: criticità di sistema o falso problema In: Cooperazione e competizione nel servizio sanitario. A cura di: N. Dirindin. Il Mulino,Bologna. 2003. 767. PAGANO E, CICCONE G. E GRUPPO DI LAVORO RELAZIONE EPIDEMIOLOGICA. Relazione sanitaria sull’oncologia in Piemonte: aspetti epidemiologici. Torino, <strong>CPO</strong>-Piemonte, Regione Piemonte, Rete Oncologica, novembre 2003. 768. PAGANO E, CICCONE G. La radioterapia in Piemonte: strutture, attività e fabbisogno. Anni 2001-2003. Quaderno <strong>CPO</strong> n° 11. Torino, maggio 2005. 769. PAGANO E, DI CUONZO D, BONA C, BALDI I, GABRIELE P, RICARDI U, ROTTA P, BERTETTO O, APPIANO S, MERLETTI F, SEGNAN N, CICCONE G. Accessibility as a major determinant of radiotherapy underutilization: A population based study. Health Policy 2007; 80: 483-91. 770. PAGANO E, DI CUONZO D, BONA C, BALDI I, SEGNAN N, MERLETTI F, CICCONE G. Identificazione della diagnosi oncologica di pazienti trattati presso servizi ambulatoriali di radioterapia attraverso link con le Schede di Dimissione Ospedaliera. Epidemiol Prev 2006; 30: 132-8. 771. PAGANO E, GUERRUCCI D. La formazione del conto economico consolidato delle Asl e delle aziende ospedaliere. Politiche Sanitarie 2001; 2: 57-67. 772. PAGANO E, PETRINCO M, DESIDERI A, BIGI R, MERLETTI F, GREGORI D. Survival models for cost data: the forgotten additive approach. Stat Med 2008; 27: 3585-97. (IF 1.547) 773. PAGANO E, PONTI A, GELORMINO E, MERLETTI F, MANO MP. An economic evaluation of the optimal workload in treating surgical patients in a breast unit. Eur J Cancer 2003; 39: 748-54. 50
774. PAGANO E. Come è difficile trasformare le conoscenze scientifiche in azione politica. Epidemiol Prev 2004; 28: 2. 775. PALA V, BERRINO F, VINEIS P, PALLI D, CELENTANO E, TUMINO R, KROGH V. How vegetables are eaten in Italy EPIC centres: still setting a good example IARC Sci Publ 2002; 156: 119-21. 776. PALA V, SIERI S, MASALA G, PALLI D, PANICO S, VINEIS P, SACERDOTE C, MATTIELLO A, GALASSO R, SALVINI S, CEROTI M, BERRINO F, FUSCONI E, TUMINO R, FRASCA G, RIBOLI E, TRICHOPOULOU A, BAIBAS N, KROGH V. Associations between dietary pattern and lifestyle, anthropometry and other health indicators in the elderly participants of the EPIC-Italy cohort. Nutr Metab Cardiovasc Dis 2006; 16: 186-201. 777. PALLI D, KROGH V, RUSSO A, BERRINO F, PANICO S, TUMINO R, VINEIS P. EPIC-Italy. A molecular epidemiology project on diet and cancer. AdvExpMedBiol 1999; 472: 21-8. 778. PALLI D, MASALA G, DEL GIUDICE G, PLEBANI M, BASSO D, BERTI D, E NUMANS M, CEROTI M, PEETERS PH, DE MESQUITA HB, BUCHNER FL, CLAVEL-CHAPELON F, BOUTRON-RUAULT MC, KROGH V, SAIEVA C, VINEIS P, PANICO S, TUMINO R, NYREN O, SIMAN H, BERGLUND G, HALLMANS G, SANCHEZ MJ, LARRANAGA N, BARRICARTE A, NAVARRO C, QUIROS JR, KEY T, ALLEN N, BINGHAM S, KHAW KT, BOEING H, WEIKERT C, LINSEISEN J, NAGEL G, OVERVAD K, THOMSEN RW, TJONNELAND A, OLSEN A, TRICHOUPOULOU A, TRICHOPOULOS D, ARVANITI A, PERA G, KAAKS R, JENAB M, FERRARI P, NESI G, CARNEIRO F, RIBOLI E, GONZALEZ CA. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007; 120: 859-67. 779. PALLI D, MASALA G, PELUSO M, GASPARI L, KROGH V, MUNNIA A, PANICO S, SAIEVA C, TUMINO R, VINEIS P, GARTE S. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects. Carcinogenesis 2004; 25: 577-84. 780. PALLI D, MASALA G, VINEIS P, GARTE S, SAIEVA C, KROGH V, PANICO S, TUMINO R, MUNNIA A, RIBOLI E, PELUSO M. Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults. Carcinogenesis 2003; 24: 739-46. 781. PALLI D, VINEIS P, RUSSO A, BERRINO F, KROGH V, MASALA G, MUNNIA A, PANICO S, TAIOLI E, TUMINO R, GARTE S, PELUSO M. Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer 2000; 87: 444-51. 782. PALUMBO A, BERTOLA A, FALCO P, ROSATO R, CAVALLO F, GIACCONE L, BRINGHEN S, MUSTO P, PREGNO P, CARAVITA T, CICCONE G, BOCCADORO M. Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma. Hematol J 2004; 5: 318-24. 783. PALUMBO A, BRINGHEN S, CARAVITA T, MERLA E, CAPPARELLA V, CALLEA V, CANGIALOSI C, GRASSO M, ROSSINI F, GALLI M, CATALANO L, ZAMAGNI E, PETRUCCI MT, DE STEFANO V, CECCARELLI M, AMBROSINI MT, AVONTO I, FALCO P, CICCONE G, LIBERATI AM, MUSTO P, BOCCADORO M; ITALIAN MULTIPLE MYELOMA NETWORK, GIMEMA. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet 2006; 367: 825-31. 784. PALUMBO A, BRINGHEN S, LIBERATI AM, CARAVITA T, FALCONE A, CALLEA V, MONTANARO M, RIA R, CAPALDI A, ZAMBELLO R, BENEVOLO G, DERUDAS D, DORE F, CAVALLO F, GAY F, FALCO P, CICCONE G, MUSTO P, CAVO M, BOCCADORO M. Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood 2008; 112: 3107-14. (IF 10.896) 785. PALUMBO A, BRINGHEN S, PETRUCCI MT, MUSTO P, ROSSINI F, NUNZI M, LAUTA VM, BERGONZI C, BARBUI A, CARAVITA T, CAPALDI A, PREGNO P, GUGLIELMELLI T, GRASSO M, CALLEA V, BERTOLA A, CAVALLO F, FALCO P, RUS C, MASSAIA M, MANDELLI F, CARELLA AM, POGLIANI E, LIBERATI AM, DAMMACCO F, CICCONE G, BOCCADORO M. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood 2004; 104: 3052-7. 786. PALUMBO A, FALCO P, AMBROSINI MT, PETRUCCI MT, MUSTO P, CARAVITA T, PREGNO P, BERTOLA A, CAVALLO F, CICCONE G, BOCCADORO M. Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant. Eur J Haematol 2005; 75: 391-5. 787. PALUMBO A, FALCO P, CORRADINI P, FALCONE A, DI RAIMONDO F, GIULIANI N, CRIPPA C, CICCONE G, OMEDÈ P, AMBROSINI MT, GAY F, BRINGHEN S, MUSTO P, FOÀ R, KNIGHT R, ZELDIS JB, BOCCADORO M, PETRUCCI MT; GIMEMA-- ITALIAN MULTIPLE MYELOMA NETWORK. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network. J Clin Oncol 2007; 25: 4459-65. 51
- Page 1 and 2: Centro di Riferimento per l’Epide
- Page 3 and 4: 26. ALESSI D, PASTORE G, BAGNATI R,
- Page 5 and 6: as much screening as women
- Page 7 and 8: 86. BEDESCHI E, CAMPARI C, CANDELA
- Page 9 and 10: 120. BIGGERI A, STANGHELLINI E, MER
- Page 11 and 12: 151. BO S, CICCONE G, ROSATO R, GAN
- Page 13 and 14: 181. BOYLE P, VAINIO H, SMITH R, BE
- Page 15 and 16: 211. BRUNO G, MERLETTI F, BOFFETTA
- Page 17 and 18: 243. CARNINO F, FUDA G, CICCONE G,
- Page 19 and 20: 276. CICCONE G, PRASTARO C, IVALDI
- Page 21 and 22: 308. CUCCORESE C, MANO M.P, PONTI A
- Page 23 and 24: 331. DANESH J, SARACCI R, BERGLUND
- Page 25 and 26: 362. DREASSI E, LAGAZIO C, MAULE MM
- Page 27 and 28: 393. FERREYRA GP, BAUSSANO I, SQUAD
- Page 29 and 30: 427. GEHRING U, PATTENDEN S, SLACHT
- Page 31 and 32: ecruitment phase of a large randomi
- Page 33 and 34: 489. GREGORI D, MORRA B, SNIDERO S,
- Page 35 and 36: 524. IOANNIDIS JP, BERNSTEIN J, BOF
- Page 37 and 38: 546. KAUPPINEN T, TOIKKANEN J, PEDE
- Page 39 and 40: 568. LINSEISEN J, ROHRMANN S, NORAT
- Page 41 and 42: 601. MAGNANI C, TERRACINI B, IVALDI
- Page 43 and 44: 633. MASALA G, DI LOLLO S, PICOCO C
- Page 45 and 46: 669. MERLETTI F, MIRABELLI D. Espos
- Page 47 and 48: 706. MIRABELLI D, CADUM E. [Mortali
- Page 49: BERGMANN MM, OVERVAD K, BOUTRON-RUA
- Page 53 and 54: 803. PASTORE G, MOSSO ML, MAGNANI C
- Page 55 and 56: 836. PINAMONTI B, PERKAN A, DI LENA
- Page 57 and 58: 864. PONTI A, SEGNAN N, BLAMEY R, B
- Page 59 and 60: 897. RICHIARDI L, BOFFETTA P, MERLE
- Page 61 and 62: comparing human papillomavirus test
- Page 63 and 64: 958. ROSSO S AND THE AIRTUM WORKING
- Page 65 and 66: 995. SANT M, ALLEMANI C, DE ANGELIS
- Page 67 and 68: 1026. SEGNAN N, SENORE C, GIORDANO
- Page 69 and 70: European Prospective Investigation
- Page 71 and 72: 1089. 'T MANNETJE A, KOGEVINAS M, C
- Page 73 and 74: 1136. TERRACINI B. When and why can
- Page 75 and 76: 1165. VELTRI A, GARETTO I, PAGANO E
- Page 77 and 78: 1200. VINEIS P, MALATS N, PORTA M,
- Page 79 and 80: 1247. VINEIS P. Evidence-based prim
- Page 81 and 82: SLIMANI N, NORAT T, RIBOLI E. Fruit
- Page 83: 1327. ZUCCOLO L, PASTORE G, PEARCE